Flavopiridol inhibits several cellular kinases and has demonstrated cytostatic and cytotoxic activity in vitro and in vivo in numerous human tumor
cell lines and xenograft models (including human breast, prostate, and
lung carcinoma) at clinically achievable concentrations.